231 Folgen

A podcast on medicine, oncology, & health policy.
Host: Vinay Prasad, MD MPH from University of California, San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com.

Plenary Session Vinay Prasad, MD MPH

    • Wissenschaft
    • 5,0 • 9 Bewertungen

A podcast on medicine, oncology, & health policy.
Host: Vinay Prasad, MD MPH from University of California, San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com.

    4.12 Real-World Survival Outcomes for Pertuzumab and T-DM1 with Dr. Josee-Lyne Ethier

    4.12 Real-World Survival Outcomes for Pertuzumab and T-DM1 with Dr. Josee-Lyne Ethier

    Today we interview Dr. Josee-Lyne Ethier of Queen's University in Kingston, Ontario, Canada on her new paper "Practice Patterns and Outcomes of Novel Targeted Agents for the Treatment of ERBB2-Positive Metastatic Breast Cancer", out now in JAMA Oncology. We talk about the real-world survival outcomes for pertuzumab and T-DM1, comparing these outcomes to the results of pivotal clinical trials CLEOPATRA and EMILIA.

    Practice Patterns and Outcomes: doi.org/10.1001/jamaoncol.2021.2140

    Back us on Patreon! www.patreon.com/plenarysession

    Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

    • 35 Min.
    4.11 CheckMate 274, PARADIGM-HF/Ernesto, POLO, & an AI Approach to Reducing Knee Pain

    4.11 CheckMate 274, PARADIGM-HF/Ernesto, POLO, & an AI Approach to Reducing Knee Pain

    Today's episode is a compilation of a few short monologues. We provide an oncologist's evidence-based medicine perspective on four papers: CheckMate 274, adjuvant nivolumab in urothelial cancer; PARADIGM-HF/Entresto; the POLO trial, olaparib in pancreas cancer; and the paper "An algorithmic approach to reducing unexplained pain disparities in underserved populations".

    CheckMate 274: doi.org/10.1056/NEJMoa2034442
    PARADIGM-HF: doi.org/10.1056/nejmoa1409077
    POLO: doi.org/10.1056/NEJMoa1903387
    Knee pain: doi.org/10.1038/s41591-020-01192-7

    Back us on Patreon! www.patreon.com/plenarysession

    Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

    • 54 Min.
    4.10 A Deep Dive into CheckMate 649 with Dr. Jeffrey Bien

    4.10 A Deep Dive into CheckMate 649 with Dr. Jeffrey Bien

    Today we sit down (in person!) with Dr. Jeff Bien of Stanford University to break down all the details -- from the methods to the statistical analysis to the conclusions -- of the CheckMate 649 trial, which pitted first-line nivolumab plus chemotherapy against chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma.

    CheckMate 649: doi.org/10.1016/S0140-6736(21)00797-2

    Back us on Patreon! www.patreon.com/plenarysession

    Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

    • 58 Min.
    4.09 Problems with the VISION Trial & Stool Transplant Plus Nivo for Metastatic Melanoma

    4.09 Problems with the VISION Trial & Stool Transplant Plus Nivo for Metastatic Melanoma

    Today we have two short monologues for you on recent papers. The first, by popular request, is the problems with the VISION trial, which treated metastatic castration-resistant prostate cancer with lutetium-177–PSMA-617 (Lu-177–PSMA-617) radioligand therapy and standard of care. The second is on the paper recently published in Science titled "Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients".

    Fecal transplant: doi.org/10.1126/science.abb5920

    Back us on Patreon! www.patreon.com/plenarysession

    Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

    • 26 Min.
    4.08 Implications for the Fate of Accelerated Approval from the ODAC Votes of April 2021

    4.08 Implications for the Fate of Accelerated Approval from the ODAC Votes of April 2021

    In today's quick episode, we talk about our new paper out now in JAMA Network Open titled "The Oncologic Drugs Advisory Committee Votes of April 2021—Implications for the Fate of Accelerated Approval"

    ODAC Votes: doi.org/10.1001/jamaoncol.2021.3046

    Back us on Patreon! www.patreon.com/plenarysession

    Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

    • 11 Min.
    4.07 Questions from a Medical Student with Emma Greenstreet and Dr. Vinay Prasad

    4.07 Questions from a Medical Student with Emma Greenstreet and Dr. Vinay Prasad

    We have a reverse episode for you today! Emma Greenstreet, a second-year medical student at UCSF, interviews our usual host, Dr. Vinay Prasad on why and how he chose hematology/oncology as a specialty, engaging with criticism, mentorship, medical student rotations, choosing a research project, and urging doctors in academia to aim higher.

    Back us on Patreon! www.patreon.com/plenarysession

    Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

    • 49 Min.

Kundenrezensionen

5,0 von 5
9 Bewertungen

9 Bewertungen

Top‑Podcasts in Wissenschaft

Listeners Also Subscribed To